Polymeric controlled release systems for management of bone infection

Polymers for Dental and Orthopedic Applications

Volumn , Issue , 2006, Pages 391-411

  Shalaby, Marc ^a   Shalaby, Shalaby W ^b  

^a LEHIGH VALLEY HOSPITAL   (United States)

^b Poly Med Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896547499     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (68)

1. Waldvogel, F.A., Medoff, G., and Swartz, M.W., Osteomyelitis: a review of clinical features, therapeutic considerations, and unusual aspects, New Engl. J. Med., 282, 198, 1970.
2. Dougherty, S.G., Pathology of infection in prosthetic devices, Rev. Infect. Dis., 10, 1102, 1988.
3. Calhoun, J.H. and Mader, J.T., Eds., Musculoskeletal Infections, Marcel Dekker, New York, 2003.
4. Lew, D.P. and Waldvogel, F.A., Osteomyelitis, New Engl. J. Med., 336, 999, 1997.
5. Shirtliff, M.E. and Mader, J.T., Acute septic arthritis, Clin. Microbiol. Rev., 15(4), 527, 2002.
6. Zimmerli, W., Trampuz, A., and Ochsner, P.E., Current concepts: prosthetic-joint infections, New Engl. J. Med., 351(16), 1645, 2004.
7. Darouiche, R.O., Treatment of infections associated with surgical implants, New Engl. J. Med., 350, 1422, 2004
8. Costerton, J. W, Stewart, P.S., and Greenberg, E.P., Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 1999.
9. Donlan, R.M. and Consterton, J.W., Biofilms: survival mechanisms of clinically relevant microorganisms, Clin. Microbiol. Rev., 15, 167, 2002.
10. Roisman, F.R., Walz, D.T., and Finklestein, A.E., Superoxide radical production by human leukocytes exposed to immune complexes: inhibitory action of gold compounds, Inflammation, 7, 355, 1983.
11. Garvin, K. and Feschuk, C., Polylactide-polyglycolide antibiotic implants, Clin. Orthop., 437, 105, 2005.
12. Bernard, L., El-Hajj, M., Pron, B., Lotthe, A., Gleizes, V., Signoret, F., Denormandie, P., Gaillard, J.L., and Perronne, C., Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost, J. Clin. Pharm. Ther., 26, 445, 2001.
13. Craven, P.C., Treating bone and joint infections with teicoplanin: hospitalization vs. outpatient cost issues, Hosp, Formul., 28(Suppl. 1), 41, 1993.
14. Lai, K.A., Shen, W.J., Yang, C.Y., Lin, R.M., Lin, C.J., and Jou, I.M., Two-stage cementless revision of THR after infection: 5 recurrences in 40 cases followed 2.5- 7 years, Acta Orthopaed. Scand., 67, 325, 1996.
15. Corbett, J.T., Jerome, J.E., Allan, J.A., Kelley, W., Kline, J., Farris, H., Fulton, L., and Shalaby, S.W., In vitro and in vivo release of vancomycin and gentamicin from an injectable absorbable gel-forming matrix for treating osteomyelitis, Mater. Res. Soc., Meeting Abstracts, Boston, Massachusetts, Material Research Society, Warrendale, PA, Dec. 1997, p. 351.
16. Hanssen, A.D., Local antibiotic delivery vehicles in the treatment of musculoskeletal infection, Clin. Orthop., 437, 91, 2005.
17. Kanellakopoulou, K. and Giamarellos-Bourboulis, E.J., Carrier systems for the local delivery of antibiotics in bone infections, Drugs, 59(6), 1223, 2000.
18. Allababidi, S. and Shah, J.C., Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation, J. Pharm. Sci., 87(6), 738, 1998.
19. Hanssen, A.D., Osmon, D.R., and Patel, R., Local antibiotic delivery systems: where are we and where are we going? Clin. Orthop., 437, 111, 2005
20. Nelson, C.L., The current status of material used for depot delivery of drugs, Clin. Orthop., 427, 72, 2004.
21. Buchholz, H.W. and Englebrecht, H., Depot effects of various antibiotics mixed with Palacos resins, Der Chirurg, 41, 511, 1970.
22. Wahlig, H., Gentamicin-PMMA beads: a drug delivery system in the treatment of chronic bone and soft tissue infections, J. Antimicrob. Chemother., 10, 463, 1982.
23. Cierny, G. III, Classification and treatment of adult osteomyelitis, in Surgery of the Musculoskeletal System, Evarts, C.M., Ed., Churchill Livingstone, New York, 1990, p. 4337.
24. Evans, R.P. and Nelson, C.L., Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis, Clin. Orthop., 295, 37, 1993.
25. Calhoun, J.H., Henry, S.L., Anger, D.M., and Mader, J.T., The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads, Clin. Orthop., 295, 23, 1993.
26. Espehaug, B., Engesaeter, L.B., Vollset, S.E., Havelin, L.I., and Langeland, N., Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987-1995. J. Bone Joint Surg. Br, 79(4), 590, 1997.
27. Neut, D., van de Belt, H., Strokroos, I., van Horn, J.R., van der Mei, H.C., and Busscher, H.J., Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery, J. Antimicrob. Chemother., 47, 885, 2001.
28. Langlais, F., Can we improve the results of revision arthroplasty for infected total hip replacement? J. Bone Joint Surg. Br., 85, 637–640, 2003.
29. McLaren, A.C., Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections, Clin. Orthop., 427, 101, 2004.
30. Horowitz, S.M., Gautsch, T.L., Fondoza, C.G., and Riley, Jr., L., Macrophage exposure to polymethylmethacrylate leads to mediator release and injury, J. Orthop. Res., 9, 406, 1991.
31. Schurman, D.J., Trindade, C., Hirschman, H.P., Moser, K., Kajiyama, G., and Stevens, P., Antibiotic-acrylic bone cement composites. Studies of gentamicin and Palacos, J. Bone Joint Surg. Am., 60, 978, 1978.
32. Calhoun, J.H. and Mader, J.T., Treatment of osteomyelitis with a biodegradable antibiotic implant, Clin. Orthop., 341, 206, 1997.
33. McLaren, A.C., Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections, Clin. Orthop., 427, 101, 1994.
34. Wachol-Drewek, Z., Pfeiffer, M., and Scholl, E., Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin, Biomaterials, 17(17), 1733, 1996.
35. Greco, F., de Palma, L., Spagnolo, N., Rossi, A., Specchia, N., and Gigante, A., Fibrin-antibiotic mixtures; an in vitro study assessing the possibility of using a biologic carrier for local drug delivery, J. Biomed. Mater. Res., 25, 39, 1991.
36. Redl, H., Schlag, G., Stanek, G., Hirschi, A., and Seelcih, T., In vitro properties of mixtures of fibrin seal and antibiotics, Biomaterials, 4, 29, 1983.
37. Ueng, S.W.N., Lee, S.S., Lin, S.S., Chan, E.C., Hsu, B.R., and Chen, K.T., Biodegradable alginate antibiotic beads, Clin. Orthop., 380, 250, 2000.
38. Dacquet, V., Varlet, A., Tandogan, R.N., Tahon, M.M., Fournier, L., Jehl, F., Monteil, H., and Bascoulergue, G., Antibiotic-impregnated plaster of Paris beads — trials with teicoplanin, Clin. Orthop., 282, 241, 1992.
39. Mackey, D., Varlet, A., and DeBeaumont, D., Antibiotic loaded plaster of Paris pellets, Clin. Orthop., 167, 263, 1982.
40. Mousset, B., Benoit, M.A., Delloye, C., Bouillet, R., and Gillard, J., Biodegradable implants for potential use in bone infection: an in vitro study of antibiotic-loaded calcium sulfate, Int. Orthop., 19, 157, 1995
41. Yu, D., Wong, J., Matsuda, Y., Fox, J.L., and Higuchi, W.I., Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system for antibiotics, J. Pharm. Sci., 81(6), 529, 1992.
42. Changez, M, Koul, V., and Dinda, A.K., Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for the treatment of experimental osteomyelitis: in vivo study, Biomaterials, 26(14), 2095, 2005.
43. Ellington, K., Harris, M., Hudson, M.C., Vishin, S., Webb, L.X., and Sheretz, R., Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcus osteomyelitis, J. Orthop. Res., 24, 87, 2006
44. McGavin, M.H., Krajewska-Pietrasik, D., Ryden, C., and Hook, M., Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity, Infect. Immunol., 61, 2479, 1993.
45. Arora, M., Shah, N., Meghji, S., Henderson, B., Harris, M., Nair, S., Wilson, M., Gray, C.M., Jones, S.J., and Boyde, A., Effect of Staphylococcus aureus extracellular proteinaceus fraction in an isolated osteoclastic resportion assay, J. Bone Miner. Res., 16, 158, 1998.
46. Nair, S., Song, Y., Meghji, S., Reddi, K., Harris, M., Ross, A., Poole, S., Wilson, M., and Henderson, B., Surface-associated proteins from Staphylococcus aureus demonstrate potent bone resorbing activity, J. Bone Miner. Res., 10, 726, 1995.
47. Hudson, M.C., Ramp, W.K., Nicholson, N.C., Williams, A.S., and Nousiainen, M.T., Internalization of Staphylococcus aureus by cultured osteoblasts, Microb. Pathog., 19, 409, 1995.
48. Jevon, M., Guo, C., Ma, B., Mordan, J., Nair, S.P., Harris, M., Henderson, B., Bentley, G., and Meghji, S., Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblast, Infect. Immunol., 67, 2677, 1999.
49. Garvin, K.L., Miyano, J.A., and Robinson, D., Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis: a canine model, J. Bone Joint Surg., Am., 76, 1500, 1994.
50. Hendricks, K.J., Lane, D., Burd, T.A., Lowry, K.J., Day, D., Phaup, J.G., and Anglen, J.O., Elution characteristics of tobramycin from polycaprolactone in a rabbit model, Clin. Orthop., 392, 418, 2001.
51. Bostman, O.M., Current concepts review. Absorbable implants for the fixation of fractures, J. Bone Joint Surg., 73-A, 148, 1991.
52. Bostman, O., Hirvensalo, E., Makinen, J., and Rokkanen, P., Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers, J. Bone Joint Surg., 72-B(4), 592, 1990.
53. Tamada, J. and Langer, R., The development of polyanhydrides for drug delivery applications, J. Biomater. Sci. Polym. Ed., 3, 315, 1992.
54. Burd, T.A., Anglen, J.O., Lowry, K.J., Hendricks, K.J., and Day, D., In vitro elution of tobramycin from bioabsorbable polycaprolactone beads, J. Orthop. Trauma, 15(6), 424, 2001.
55. Rutledge, B., Huyette, D., Day, D., and Anglen, J., Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer, Clin. Orthop., 411, 280, 2003.
56. Laurencin, C.T., Gerhart, T., Witschger, P., Satcher, R., Domb, A., Rosenberg, A.E., Hanff, P., Edsberg, L., Hayes, W., and Langer R., Bioerodible polyanhydrides for antiobiotic drug delivery: in vivo osteomyelitis treatment in a rat model system, J. Orthop. Res., 11, 256, 1993.
57. Hatefi, A. and Amsden, B., Biodegradable injectable in situ forming drug delivery systems, J. Control Release, 80, 9, 2002.
58. Couvreur, P., Fattal, E., and Andremont, A., Liposomes and nanoparticles in the treatment of intracellular bacterial infections, Pharm. Res., 8, 1079, 1991.
59. Pinto-Alphandary, H., Andremont, A., and Couvreur, P., Targeted delivery of antibiotics using liposomes and nanaoparticles: research and applications, Int. J. Antimicrob. Agents, 13, 155, 2000.
60. Yeh, H.Y. and Huang, Y.Y., Injectable biodegradable polymeric implants for the prevention of postoperative infection: implications for antimicrobial resistance, Am. J. Drug Deliv., 1(3), 149, 2003.
61. Ambrose, C.G., Gogola, G.R., Clyburn, T.A., Raymond, A.K., Peng, A.S., and Mikos, A.G., Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis, Clin. Orthop., 415, 279, 2003.
62. Yenice, I., Calis, S., Atilla, B., Kas, H.S., Ozlap, M., Ekizoglu, M., Bilgili, H., and Hincal, A.A., In vitro-in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects, J. Microencapsulation, 20(6), 705, 2003.
63. Corbett, J.T., Kelly, W., Farris, H., Fulton, L., Jerome, J.E., Kline, J.D., Allan, J.M., and Shalaby, S.W., Absorbable gel-forming system for controlled release of vancomycin for treating osteomyelitis, Trans. Soc. Biomater., 21, 341, 1998.
64. Corbett, J.T., Kelly, J.W., Dooley, R.L., Fulton, L.K., and Shalaby, S.W., Development of an animal model for evaluation of antibiotic controlled release systems for the management of osteomyelitis, Trans. Soc. Biomater., 24, 292. 2001.
65. Chein, Y.W. in Drug Delivery Systems, Juliano, R.L., Ed., Oxford University Press, New York, 1980, chap. 2.
66. Chang, C.C. and Kinal, F.A., Sustained release hormonal preparations. Biological effectiveness of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione, Steroids, 12, 689, 1968.
67. Le Ray, A.M., Chiffoleau, S., Iooss, P., Grimandi, G., Gouyette, A., Daculsi, G., and Merle, C., Vancomycin encapsulation in biodegradable poly(-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility, Biomaterials, 24, 443, 2003.
68. Billion, A., Chabaud, L., Gouyette, A., Bouler, J.-M., and Merle, C., Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release, J. Microencapsulation, 22(8), 841, 2005.